Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Cardio Pharm Quiz > Anti-Platelets/Anti-Coagulants > Flashcards

Anti-Platelets/Anti-Coagulants Flashcards

1
Q

dabigatran category of drug

A

oral direct acting thrombin inhibitor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

drug interactions with warfarin

A
  • NSAIDS- Amiodarone- Cimetidine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

UFH/LMWH MOA

A
  • inhibits factors Xa and thrombin by acting on anti-thrombin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

when do we give fibrinolytic drugs?

A
  • immediately to treat STEMIS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

enoxaparin is given how?

A
  • subQ
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

half life of factor 10a

A
  • 40 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

warfarin/coumadin category of drugs

A

oral indirect acting vitamin K inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

P2y12 inhibitors MOA

A
  • irreversibly block ADP receptor binding for platelets

- non competitive antagonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of warfarin

A
  • vitamin K reductase inhibitor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is an alternative to heparin in patients with HIT?

A
  • argatroban
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how do we manage until warfarin kicks in?

A
  • heparin bridging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

argatroban category of druggiven how

A
  • direct acting thrombin inhibitor

- IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

COX1/2 inhibitors used to treat

A
  • unstable angina- MI- stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

P2y12 inhibitors used to treat

A
  • MI - stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

how must GPIIb/IIIa inhibitors be given?

A
  • IV
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

before warfarin effects begin, what must happen?

A
  • affected coagulation factors must degrade
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

diet and warfarin

A
  • variability in diet makes warfarin dosing problematic

- dependent on vitamin K intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

half life of factor 7a

A
  • 6 hours
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what proteins is vitamin K responsible for

A
  • 2- 7- 9- 10- proteins C and S
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

GPIIb/IIIa inhibitors MOA

A
  • prevent activated platelets from sticking together
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Abciximab class of drug

A
  • GPIIb/IIIa inhibitor
22
Q

what part of heparin binds to the anti-thrombin

A
  • the pentasaccharide
23
Q

toxicities of COX 1/2 inhibitors

A
  • gastric damage
24
Q

when do we give Streptokinase or alteplase

A
  • immediately to treat pulmonary emboli
25
Q

fondaparinux MOA

A
  • inhibits factor Xa by acting on anti-thrombin
26
Q

half life of factor 2a (thrombin)

27
Q

UFH toxicities

A
  • heparin-induced thrombocytopenia
28
Q

unfractionated heparin and enoxaparin category of drug

A
  • indirect acting thrombin and factor Xa inhibitors
29
Q

half life of factor 9a

30
Q

role of Alteplase and Streptokinasehow must they be administered

A
  • proteins that convert inactive plasminogen into active plasmin
  • IV because they are large molecules
31
Q

fondaparinux category of druggiven how

A
  • indirect acting factor Xa inhibitor

- SubQ

32
Q

fibrinolytics should definitely not be used for

A
  • strokes caused by cerebral hemorrhage

- those patients who for blood clotting is good

33
Q

unfractionated heparin is given how?

A
  • IV- SubQ- too large a molecular size
34
Q

COX1/2 inhibitors MOA

A
  • inhibit COX synthesis of TXA2
35
Q

Pharmacokinetics issues with wafarin

A
  • slow onset of action
  • may take up to a week to reach therapeutic levels
  • polymorphism issues
  • variability in diet
36
Q

When can we also give alteplase

A
  • immediately to treat stroke
37
Q

aspirin class of drug

A
  • COX1/2 inhibitor
38
Q

how Amiodarone and Cimetidine interact with warfarin

A
  • decrease warfarin metabolism

- increase INR

39
Q

Tirofiban class of drug

A
  • GPIIb/IIIa inhibitor
40
Q

how does heparin-induced thrombocytopenia occur

A
  • platelet coated with immune complex and heparin

- platelet removed by splenic macrophages

41
Q

Eptifibitide class of drug

A
  • GPIIb/IIIa inhibitor
42
Q

how NSAIDS impact warfarin

A
  • kick warfarin off albumin- increase free warfarin- increase bleeding risk
43
Q

clopidogrel class of drug

A
  • P2y12 inhibitors
44
Q

platelet activation is what phase of hemostasis?

A
  • primary hemostasis
45
Q
  • apixaban, rivaroxaban, edoxaban category of drug
A

oral direct acting factor Xa inhibitor

46
Q

GPIIb/IIIa inhibitors used to treat

A
  • angioplasty- stent placement
47
Q

what is fondaparinux really?

A
  • only the pentasaccharide portion of heparin
48
Q

Warfarin toxicities

A
  • birth defects- fetal warfarin syndrome- category X toxin
49
Q

thrombin activation is what phase of hemostasis?

A
  • secondary hemostasis
50
Q

Pharmacokinetics issues with P2y12 inhibitors

A
  • given in the prodrug form first
  • must be activated by CYP2C19-
    slow metabolizers (activators) will have reduced therapeutic effects
51
Q

role of TXA2

A
  • platelet activation and aggregation
52
Q

which polymorphisms affect warfarin dosing?

A
  • VKORC1- CYP2C9

Cardio Pharm Quiz (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions